Publications

Export 27 results:
Author Title Type [ Year(Asc)]
Filters: Author is Sylvia Villeneuve  [Clear All Filters]
2021
Gonneaud J, Baria AT, Binette APichet, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M et al..  2021.  Accelerated functional brain aging in pre-clinical familial Alzheimer's disease.. Nat Commun. 12(1):5346.
Picard C, Nilsson N, Labonte A, Auld D, Rosa-Neto P, Ashton NJ, Zetterberg H, Blennow K, Breitner JCS, Villeneuve S et al..  2021.  Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.. Alzheimers Dement.
Nilsson NIV, Picard C, Labonte A, Köbe T, Meyer P-F, Villeneuve S, Auld D, Poirier J.  2021.  Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum.. Genes (Basel). 12(11)
Binette APichet, Theaud G, Rheault F, Roy M, D Collins L, Levin J, Mori H, Lee JHong, Farlow MRhys, Schofield P et al..  2021.  Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease.. Elife. 10
Tremblay-Mercier J, Madjar C, Das S, Binette APichet, Dyke SOM, Etienne P, Lafaille-Magnan M-E, Remz J, Bellec P, D Collins L et al..  2021.  Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease.. Neuroimage Clin. 31:102733.
Morrison C, Dadar M, Shafiee N, Villeneuve S, D Collins L.  2021.  Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline.. Neuroimage Clin. 33:102923.
Köbe T, Binette APichet, Vogel JW, Meyer P-F, Breitner JCS, Poirier J, Villeneuve S.  2021.  Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes.. Neuroimage. 231:117832.
2020
Binette APichet, Vachon-Presseau E, Morris J, Bateman R, Benzinger T, D Collins L, Poirier J, Breitner JCS, Villeneuve S.  2020.  Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.. Biol Psychiatry.
Gonneaud J, Bedetti C, Binette APichet, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S.  2020.  Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease.. Neurology. 95(11):e1554-e1564.
Han JWon, Maillard P, Harvey D, Fletcher E, Martinez O, Johnson DK, Olichney JM, Farias ST, Villeneuve S, Jagust W et al..  2020.  Association of vascular brain injury, neurodegeneration, amyloid and cognitive trajectory.. Neurology.
Ossenkoppele R, Leuzy A, Cho H, Sudre CH, Strandberg O, Smith R, Palmqvist S, Mattsson-Carlgren N, Olsson T, Jögi J et al..  2020.  The impact of demographic, clinical, genetic, and imaging variables on tau PET status.. Eur J Nucl Med Mol Imaging.
Binette APichet, Gonneaud J, Vogel JW, La Joie R, Rosa-Neto P, D Collins L, Poirier J, Breitner JCS, Villeneuve S, Vachon-Presseau E.  2020.  Morphometric network differences in ageing versus Alzheimer's disease dementia.. Brain. 143(2):635-649.
Marchant NL, Lovland LR, Jones R, Binette APichet, Gonneaud J, Arenaza-Urquijo EM, Chételat G, Villeneuve S.  2020.  Repetitive negative thinking is associated with amyloid, tau, and cognitive decline.. Alzheimers Dement. 16(7):1054-1064.

Pages